Supernus Pharmaceuticals, Inc. trademarks
Supernus Pharmaceuticals, Inc. owns 49 U.S. trademark filings (12 live registrations), with 1 TTAB proceedings. See filings by year, classes, attorneys and…
Recent trademark filings
- RETHINK ADHD SYMPTOM CONTROL
- QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
- ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
- ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
- QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES
- YESFYNA
- QEBSEROS
- EBSEROS
- YEZFYNA
- EBSEROS
View the full Supernus Pharmaceuticals, Inc. trademark profile on Marksy